Table 1 Baseline characteristics of the patients with pseudolithiasis
From: Ceftriaxone-associated pseudolithiasis in hemodialysis patients: a case series study
Patient | Age/sex | Duration of dialysis after starting ceftriaxone (days)a | BMI | Primary disease/comorbidity | Infection site | CVD | Fasting | Bed-bound | Ca-containing drug | Serum Alb (g/dL) | Adjusted serum Ca (mg/dL) | Int-PTH (pg/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 85/F | 1170 | 14.7 | MPA | Lung | − | − | + | − | 1.4 | 10.4 | 48 |
2 | 82/M | 1215 | 18.9 | DM | Unknown | + | − | − | + | 3.0 | 8.8 | 87 |
3 | 83/F | −1a | 20.6 | DM | Lung | + | − | + | − | 2.7 | 8.8 | 365 |
4 | 71/F | 2469 | 26.7 | DM | Lung | + | − | + | − | 3.4 | 10.7 | 163 |
5 | 68/M | 20 | 18.4 | SLE | Lung | − | − | + | − | 1.8 | 9.6 | 81 |
6 | 83/M | 928 | 18.1 | DM | Lung | + | − | + | + | 3.0 | 9.5 | 132 |
7 | 65/M | −2a | 27.9 | IRGN | Lung, penile abscess | − | − | − | − | 2.0 | 9.7 | − |
8 | 85/M | 8 | 16.2 | Unknown/CO2 narcosis | Lung | − | − | + | − | 3.1 | 8.9 | 252 |
9 | 32/F | 868 | 17.6 | FSGS | Lung | − | − | − | − | 3.5 | 9.5 | 113 |
10 | 82/M | 0 | 19.6 | DM | Lung | + | − | − | − | 3.7 | 9.1 | 69 |
11 | 70/M | 1065 | 20.2 | CGN/spinal cord injury | Lung | − | − | + | − | 2.8 | 8.8 | 116 |